Cargando…
Expression of androgen receptor in non-muscle-invasive bladder cancer predicts the preventive effect of androgen deprivation therapy on tumor recurrence
Our recent retrospective study revealed a significantly reduced risk of bladder cancer (BC) recurrence in men who received androgen deprivation therapy (ADT) for their prostate cancer. However, whether androgen receptor (AR) signals contributed to the preventive effect of ADT remained unclear becaus...
Autores principales: | Izumi, Koji, Ito, Yusuke, Miyamoto, Hiroshi, Miyoshi, Yasuhide, Ota, Junichi, Moriyama, Masatoshi, Murai, Tetsuo, Hayashi, Hiroyuki, Inayama, Yoshiaki, Ohashi, Kenichi, Yao, Masahiro, Uemura, Hiroji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924704/ https://www.ncbi.nlm.nih.gov/pubmed/26885620 http://dx.doi.org/10.18632/oncotarget.7358 |
Ejemplares similares
-
Androgen deprivation therapy prevents bladder cancer recurrence
por: Izumi, Koji, et al.
Publicado: (2014) -
Androgen receptor mRNA expression is a predictor for recurrence-free survival in non-muscle invasive bladder cancer
por: Yasui, Masato, et al.
Publicado: (2019) -
Efficacy of Immediate Switching from Bicalutamide to Flutamide as Second-Line Combined Androgen Blockade
por: Yokomizo, Yumiko, et al.
Publicado: (2016) -
Fluorescent Light-Guided Cystoscopy with 5-ALA Aids in Accurate Surgical Margin Detection for TURBO: A Case Report
por: Takamoto, Daiji, et al.
Publicado: (2018) -
Duration of androgen deprivation therapy with maximum androgen blockade for localized prostate cancer
por: Fujimoto, Naohiro, et al.
Publicado: (2011)